Novartis
HARBOR September 8 · Lp(a)HORIZON September 4
Two studies. Two separate announcements.
V Novartis said HARBOR missed its primary endpoint on September 8. Its September 4 Lp(a)HORIZON announcement also reported a missed primary endpoint. These were trial updates, not an earnings release.
X The original briefing reported sharp premarket weakness and spillover concern in healthcare. It compressed the two announcement dates; this edition keeps them separate.
I would separate the value attributed to each program from the value of the existing business. A read-through to other drug developers needs a program-by-program comparison; a shared disease area is not enough.